English
简体中文
Total: £ 56.28
Published Date: 2026-03-25 | Pages: 90 | Tables: 98 | Pharma & Healthcare
The global Antisense Oligonucleotides (ASO) Therapy market was valued at US$ 4654 million in 2025 and is anticipated to reach US$ 14040 million by 2032, at a CAGR of 17.3% from 2026 to 2032.
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
The North American market for Antisense Oligonucleotides (ASO) Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Antisense Oligonucleotides (ASO) Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Antisense Oligonucleotides (ASO) Therapy in Neuromuscular Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Antisense Oligonucleotides (ASO) Therapy include Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Antisense Oligonucleotides (ASO) Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antisense Oligonucleotides (ASO) Therapy. The Antisense Oligonucleotides (ASO) Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antisense Oligonucleotides (ASO) Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antisense Oligonucleotides (ASO) Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ionis Pharmaceuticals
Biogen
Sobi
Nippon Shinyaku
Jazz Pharmaceuticals
Segment by Type
Intrathecal Injection
Intravenous Injections
Other
Segment by Application
Neuromuscular Diseases
hATTR
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Antisense Oligonucleotides (ASO) Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Intrathecal Injection
1.2.3 Intravenous Injections
1.2.4 Other
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotides (ASO) Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neuromuscular Diseases
1.3.3 hATTR
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotides (ASO) Therapy Market Perspective (2021–2032)
2.2 Global Antisense Oligonucleotides (ASO) Therapy Growth Trends by Region
2.2.1 Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Antisense Oligonucleotides (ASO) Therapy Historic Market Size by Region (2021–2026)
2.2.3 Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Region (2027–2032)
2.3 Antisense Oligonucleotides (ASO) Therapy Market Dynamics
2.3.1 Antisense Oligonucleotides (ASO) Therapy Industry Trends
2.3.2 Antisense Oligonucleotides (ASO) Therapy Market Drivers
2.3.3 Antisense Oligonucleotides (ASO) Therapy Market Challenges
2.3.4 Antisense Oligonucleotides (ASO) Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotides (ASO) Therapy Players by Revenue
3.1.1 Global Top Antisense Oligonucleotides (ASO) Therapy Players by Revenue (2021–2026)
3.1.2 Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Antisense Oligonucleotides (ASO) Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Antisense Oligonucleotides (ASO) Therapy Revenue
3.4 Global Antisense Oligonucleotides (ASO) Therapy Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotides (ASO) Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides (ASO) Therapy Revenue in 2025
3.5 Global Key Players of Antisense Oligonucleotides (ASO) Therapy Head Offices and Areas Served
3.6 Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Products and Applications
3.7 Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Antisense Oligonucleotides (ASO) Therapy Breakdown Data by Type
4.1 Global Antisense Oligonucleotides (ASO) Therapy Historic Market Size by Type (2021–2026)
4.2 Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Type (2027–2032)
5 Antisense Oligonucleotides (ASO) Therapy Breakdown Data by Application
5.1 Global Antisense Oligonucleotides (ASO) Therapy Historic Market Size by Application (2021–2026)
5.2 Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)
6.2 North America Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)
6.4 North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)
7.2 Europe Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)
7.4 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)
8.2 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)
9.2 Latin America Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)
9.4 Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size (2021–2032)
10.2 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Details
11.1.2 Ionis Pharmaceuticals Business Overview
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Introduction
11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
11.1.5 Ionis Pharmaceuticals Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Antisense Oligonucleotides (ASO) Therapy Introduction
11.2.4 Biogen Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
11.2.5 Biogen Recent Development
11.3 Sobi
11.3.1 Sobi Company Details
11.3.2 Sobi Business Overview
11.3.3 Sobi Antisense Oligonucleotides (ASO) Therapy Introduction
11.3.4 Sobi Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
11.3.5 Sobi Recent Development
11.4 Nippon Shinyaku
11.4.1 Nippon Shinyaku Company Details
11.4.2 Nippon Shinyaku Business Overview
11.4.3 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Introduction
11.4.4 Nippon Shinyaku Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
11.4.5 Nippon Shinyaku Recent Development
11.5 Jazz Pharmaceuticals
11.5.1 Jazz Pharmaceuticals Company Details
11.5.2 Jazz Pharmaceuticals Business Overview
11.5.3 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Introduction
11.5.4 Jazz Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
11.5.5 Jazz Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Intrathecal Injection
Table 3. Key Players of Intravenous Injections
Table 4. Key Players of Other
Table 5. Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million), 2021–2026
Table 8. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Region (2021–2026)
Table 9. Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Region (2027–2032)
Table 11. Antisense Oligonucleotides (ASO) Therapy Market Trends
Table 12. Antisense Oligonucleotides (ASO) Therapy Market Drivers
Table 13. Antisense Oligonucleotides (ASO) Therapy Market Challenges
Table 14. Antisense Oligonucleotides (ASO) Therapy Market Restraints
Table 15. Global Antisense Oligonucleotides (ASO) Therapy Revenue by Players (US$ Million), 2021–2026
Table 16. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Players (2021–2026)
Table 17. Global Top Antisense Oligonucleotides (ASO) Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Antisense Oligonucleotides (ASO) Therapy Revenue, 2025
Table 18. Ranking of Global Top Antisense Oligonucleotides (ASO) Therapy Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Antisense Oligonucleotides (ASO) Therapy Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Headquarters and Area Served
Table 21. Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Products and Applications
Table 22. Global Key Players of Antisense Oligonucleotides (ASO) Therapy, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Type (US$ Million), 2021–2026
Table 25. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Type (2021–2026)
Table 26. Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Type (2027–2032)
Table 28. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Application (US$ Million), 2021–2026
Table 29. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Application (2021–2026)
Table 30. Global Antisense Oligonucleotides (ASO) Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Application (2027–2032)
Table 32. North America Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026
Table 34. North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country (US$ Million), 2027–2032
Table 47. Ionis Pharmaceuticals Company Details
Table 48. Ionis Pharmaceuticals Business Overview
Table 49. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product
Table 50. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026
Table 51. Ionis Pharmaceuticals Recent Development
Table 52. Biogen Company Details
Table 53. Biogen Business Overview
Table 54. Biogen Antisense Oligonucleotides (ASO) Therapy Product
Table 55. Biogen Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026
Table 56. Biogen Recent Development
Table 57. Sobi Company Details
Table 58. Sobi Business Overview
Table 59. Sobi Antisense Oligonucleotides (ASO) Therapy Product
Table 60. Sobi Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026
Table 61. Sobi Recent Development
Table 62. Nippon Shinyaku Company Details
Table 63. Nippon Shinyaku Business Overview
Table 64. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product
Table 65. Nippon Shinyaku Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026
Table 66. Nippon Shinyaku Recent Development
Table 67. Jazz Pharmaceuticals Company Details
Table 68. Jazz Pharmaceuticals Business Overview
Table 69. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product
Table 70. Jazz Pharmaceuticals Revenue in Antisense Oligonucleotides (ASO) Therapy Business (US$ Million), 2021–2026
Table 71. Jazz Pharmaceuticals Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report
List of Figures
Figure 1. Antisense Oligonucleotides (ASO) Therapy Picture
Figure 2. Global Antisense Oligonucleotides (ASO) Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Type: 2025 vs 2032
Figure 4. Intrathecal Injection Features
Figure 5. Intravenous Injections Features
Figure 6. Other Features
Figure 7. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Application: 2025 vs 2032
Figure 9. Neuromuscular Diseases Case Studies
Figure 10. hATTR Case Studies
Figure 11. Other Case Studies
Figure 12. Antisense Oligonucleotides (ASO) Therapy Report Years Considered
Figure 13. Global Antisense Oligonucleotides (ASO) Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Antisense Oligonucleotides (ASO) Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Region: 2025 vs 2032
Figure 16. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Players in 2025
Figure 17. Global Antisense Oligonucleotides (ASO) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Antisense Oligonucleotides (ASO) Therapy Revenue in 2025
Figure 19. North America Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)
Figure 21. United States Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)
Figure 25. Germany Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Share by Region (2021–2032)
Figure 33. China Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)
Figure 41. Mexico Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Share by Country (2021–2032)
Figure 45. Israel Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Antisense Oligonucleotides (ASO) Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
Figure 49. Biogen Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
Figure 50. Sobi Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
Figure 51. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
Figure 52. Jazz Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides (ASO) Therapy Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
